All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @triplehgh on TikTok · 52s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @triplehgh's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00You don't know what dogs about how small TRT shots are if you're doing daily shots every day
  2. 0:06Of TRT if they like point one or point two or something that it's a good
  3. 0:10I feel like you're damn near natural at that point. It's like such little mental oil. It's like is this even fucking doing anything
  4. 0:15That's a little aspid oil really
  5. 0:18I think we're gonna say now guys if you were on to your take you could just clear natural
  6. 0:25You got my stable approval guys. I'm here to you are considered natural my book
  7. 0:30And you're just fucking badly scraping by here that little bit of oil
  8. 0:34Even finding the right places to go in your body and to highly doubt it
  9. 0:38That's what they were giving them like
  10. 0:41them like
  11. 0:42TikToks over and also for that where it's like
  12. 0:44It's hard to go from this to this. That's me. It's a guitar to go from 3cc to point three
  13. 0:50Saint Gabriel

@triplehgh's 'TRT is natty' claim, fact-checked

TripleHGH

TikTok creator

55.7K viewsWatch on TikTok

Quick answer

The creator describes small-volume daily testosterone injections (0.1-0.2 mL) as making users 'near natural,' conflating injection volume with hormonal effect. Clinically, daily subcutaneous testosterone protocols do produce more stable serum levels than weekly injections, but any exogenous testosterone dose sufficient to maintain therapeutic serum levels will suppress endogenous LH, FSH, and testicular testosterone production. The volume of oil in a syringe is pharmacologically irrelevant to HPG axis suppression.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @triplehgh's 'TRT is natty' claim, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@triplehgh's 'TRT is natty' claim, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@triplehgh's 'TRT is natty' claim, fact-checked" from TripleHGH. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes small-volume daily testosterone injections (0.

The reason this review is not generic is the source wording and the canonical claim label "trt trt is natty in my book." In this clip, the useful excerpt is: "You don't know what dogs about how small TRT shots are if you're doing daily shots every day Of TRT if they like point one or point two or something that it's a good I feel like you're damn near natural at that point." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

140 mg per week (0.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes small-volume daily testosterone injections (0.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes small-volume daily testosterone injections (0.1-0.2 mL) as making users 'near natural,' conflating injection volume with hormonal effect. Clinically, daily subcutaneous testosterone protocols do produce more stable serum levels than weekly injections, but any exogenous testosterone dose sufficient to maintain therapeutic serum levels will suppress endogenous LH, FSH, and testicular testosterone production. The volume of oil in a syringe is pharmacologically irrelevant to HPG axis suppression.
  • Injection volume in mL measures carrier oil, not testosterone dose. A 0.1 mL injection of 200 mg/mL testosterone cypionate delivers 20 mg of active hormone.
  • 140 mg per week (0.1 mL daily at 200 mg/mL) is a standard TRT dose and reliably suppresses endogenous testosterone production via HPG axis feedback.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Injection volume in mL measures carrier oil, not testosterone dose. A 0.1 mL injection of 200 mg/mL testosterone cypionate delivers 20 mg of active hormone.
  • 140 mg per week (0.1 mL daily at 200 mg/mL) is a standard TRT dose and reliably suppresses endogenous testosterone production via HPG axis feedback.
  • Bhasin et al. (2001, NEJM) demonstrated that exogenous testosterone causes dose-dependent suppression of LH and FSH even at standard therapeutic levels.
  • Daily subcutaneous testosterone protocols do produce more stable serum levels with smaller peak-trough swings than weekly injections, which is a legitimate clinical advantage.
  • Ramasamy et al. (2014, Journal of Urology) found that low-dose daily protocols maintain therapeutic serum testosterone with reduced supraphysiologic spikes, but this does not make users hormonally natural.
  • No competitive sports organization or biological definition of 'natural' accounts for injection volume. Exogenous testosterone use is exogenous testosterone use.
  • If you are evaluating a TRT protocol, serum testosterone, LH, FSH, and hematocrit labs matter. Syringe volume does not.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @triplehgh actually say?

The creator's argument boils down to this: if you're injecting tiny daily doses of testosterone, say 0.1 or 0.2 mL, the volume is so small it barely counts. "You could just clear natural," he says, offering his personal approval that low-dose daily TRT users are "considered natural" in his book. He also references the psychological difficulty of going from a large injection volume, like 3 mL, down to 0.3 mL, framing micro-dosing as almost indistinguishable from not using testosterone at all. The transcript is messy, but that's the core claim: small oil volume equals near-natural status.

To be fair, he's not entirely making this up from nowhere. Daily subcutaneous testosterone protocols do exist in clinical practice, and the volumes involved are genuinely small. The question is whether volume has anything to do with physiological effect, and that's where things fall apart pretty quickly.

Does the science back this up?

No. Volume of oil in a syringe has no bearing on whether testosterone is suppressing your hypothalamic-pituitary-gonadal axis. What matters is the total weekly dose in milligrams and the resulting serum testosterone concentration. A 0.1 mL injection of testosterone cypionate at 200 mg/mL still delivers 20 mg of active hormone. Do that daily and you're at 140 mg per week, which is a standard therapeutic dose, and well above the threshold that shuts down endogenous testosterone production.

Bhasin et al. (2001, New England Journal of Medicine) demonstrated dose-dependent suppression of LH and FSH even at modest exogenous testosterone doses. Suppression of the HPG axis begins at serum testosterone levels that most TRT protocols easily exceed. Katz et al. (2016, Journal of Clinical Endocrinology and Metabolism) confirmed that exogenous testosterone, regardless of delivery method or frequency, reliably suppresses gonadotropins. Small syringe, same story.

What did they get wrong (or right)?

Let's give credit where it's due: daily subcutaneous injections do produce more stable serum testosterone levels with smaller peaks and troughs compared to weekly or biweekly intramuscular injections. Trough levels are less dramatic. Some clinicians do prefer this method for that reason. If his point is that daily micro-dosing is a more physiologically stable protocol, there's legitimate clinical support for that framing.

But "near natural" is simply inaccurate, and it's the kind of inaccuracy that could genuinely mislead someone. Your body does not measure naturalness by mL. It measures circulating androgens. Once exogenous testosterone is present, your testes get the signal to stop producing their own. There is no volume of oil so small that it avoids this. The creator conflates the psychological experience of injecting a tiny amount with the pharmacological reality of what that amount does inside the body. Those are completely different things. That conflation is the core error here.

What should you actually know?

If you're on TRT, you are not natural by any competitive or biological definition, regardless of your injection frequency or volume. That's not a moral judgment, it's just physiology. Your endogenous testosterone production is suppressed while you're on exogenous testosterone. That's precisely why TRT works for hypogonadal men: it replaces what the body has stopped making on its own.

Daily dosing protocols are used clinically and do have advantages, including more stable hormone levels and potentially fewer side effects related to peak-trough fluctuations. A study by Ramasamy et al. (2014, Journal of Urology) noted that low-dose daily protocols can maintain adequate serum levels with less supraphysiologic spiking. But "less spiking" is not the same as "natural." If you're evaluating TRT for medical reasons, talk to a licensed provider who can look at your actual labs, not a syringe volume. The amount of oil in the barrel tells you almost nothing about what your hormone panel looks like.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

TripleHGH · TikTok creator

55.7K views on this video

TRT is natty in my book

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about injection volume in ml measures carrier oil, not testosterone dose.?

Injection volume in mL measures carrier oil, not testosterone dose. A 0.1 mL injection of 200 mg/mL testosterone cypionate delivers 20 mg of active hormone.

What does the video say about 140 mg per week (0.1 ml daily at 200 mg/ml)?

140 mg per week (0.1 mL daily at 200 mg/mL) is a standard TRT dose and reliably suppresses endogenous testosterone production via HPG axis feedback.

What does the video say about bhasin et al. (2001, nejm) demonstrated?

Bhasin et al. (2001, NEJM) demonstrated that exogenous testosterone causes dose-dependent suppression of LH and FSH even at standard therapeutic levels.

What does the video say about daily subcutaneous testosterone protocols do produce more stable serum levels?

Daily subcutaneous testosterone protocols do produce more stable serum levels with smaller peak-trough swings than weekly injections, which is a legitimate clinical advantage.

What does the video say about ramasamy et al. (2014, journal of urology) found?

Ramasamy et al. (2014, Journal of Urology) found that low-dose daily protocols maintain therapeutic serum testosterone with reduced supraphysiologic spikes, but this does not make users hormonally natural.

What does the video say about no competitive sports?

No competitive sports organization or biological definition of 'natural' accounts for injection volume. Exogenous testosterone use is exogenous testosterone use.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by TripleHGH, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.